[
  {
    "ts": null,
    "headline": "Earnings live: Lyft stock tanks on operating loss, Robinhood falls, Ford edges higher",
    "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
    "url": "https://finnhub.io/api/news?id=006a12c9c774c745805538ca7ce916246292025d709b0c486aa261a29226f9a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770760978,
      "headline": "Earnings live: Lyft stock tanks on operating loss, Robinhood falls, Ford edges higher",
      "id": 139036433,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
      "url": "https://finnhub.io/api/news?id=006a12c9c774c745805538ca7ce916246292025d709b0c486aa261a29226f9a7"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Mixed Late Afternoon",
    "summary": "Health care stocks were mixed late Tuesday afternoon, with the NYSE Health Care Index adding 0.4% an",
    "url": "https://finnhub.io/api/news?id=899ff9c97524c0d82e7c2f11fd0f99d761f2005cb4ea973c576c7355d588aebc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770756231,
      "headline": "Sector Update: Health Care Stocks Mixed Late Afternoon",
      "id": 139036420,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Health care stocks were mixed late Tuesday afternoon, with the NYSE Health Care Index adding 0.4% an",
      "url": "https://finnhub.io/api/news?id=899ff9c97524c0d82e7c2f11fd0f99d761f2005cb4ea973c576c7355d588aebc"
    }
  },
  {
    "ts": null,
    "headline": "Rotation Lifts Energy 23% as Tech Slips Since Oct. 28",
    "summary": "Investors rotate from crowded tech into energy, materials, and industrials as market leadership begins to broaden.",
    "url": "https://finnhub.io/api/news?id=c026904882e66914b8c5d0ed2f0b4c441c6340647df78918fc4dd95ccc556d16",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770750210,
      "headline": "Rotation Lifts Energy 23% as Tech Slips Since Oct. 28",
      "id": 139035087,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Investors rotate from crowded tech into energy, materials, and industrials as market leadership begins to broaden.",
      "url": "https://finnhub.io/api/news?id=c026904882e66914b8c5d0ed2f0b4c441c6340647df78918fc4dd95ccc556d16"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Mixed Tuesday Afternoon",
    "summary": "Health care stocks were mixed Tuesday afternoon, with the NYSE Health Care Index adding 0.3% and the",
    "url": "https://finnhub.io/api/news?id=7852fc9d1209ccc6f1598b89fd1802260c4d5b8730afdf93daca65fd8f52c461",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770749126,
      "headline": "Sector Update: Health Care Stocks Mixed Tuesday Afternoon",
      "id": 139034985,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Health care stocks were mixed Tuesday afternoon, with the NYSE Health Care Index adding 0.3% and the",
      "url": "https://finnhub.io/api/news?id=7852fc9d1209ccc6f1598b89fd1802260c4d5b8730afdf93daca65fd8f52c461"
    }
  },
  {
    "ts": null,
    "headline": "Stay informed with the top movers within the S&P500 index on Tuesday.",
    "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.",
    "url": "https://finnhub.io/api/news?id=23b2b9afcacd636e54e3d566f5e434aa79cf94d1845b87a89222e263aded5639",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770744907,
      "headline": "Stay informed with the top movers within the S&P500 index on Tuesday.",
      "id": 139033279,
      "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
      "related": "MRNA",
      "source": "ChartMill",
      "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.",
      "url": "https://finnhub.io/api/news?id=23b2b9afcacd636e54e3d566f5e434aa79cf94d1845b87a89222e263aded5639"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on Moderna: “One of the Hottest Stocks in the Market This Year”",
    "summary": "Moderna, Inc. (NASDAQ:MRNA) is one of the stocks in focus on Jim Cramer’s game plan. Cramer finished his game plan with the stock, as he commented: Finally, Friday, we’re going to hear from Moderna, one of the hottest stocks in the market this year, as people are buzzing about their personal cancer vaccines. All I […]",
    "url": "https://finnhub.io/api/news?id=06a4119caef0e620ec6cd57e6b13408bf20dc49fd85c8a6a1a9c7ac2ddb1cbdc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770739271,
      "headline": "Jim Cramer on Moderna: “One of the Hottest Stocks in the Market This Year”",
      "id": 139033806,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna, Inc. (NASDAQ:MRNA) is one of the stocks in focus on Jim Cramer’s game plan. Cramer finished his game plan with the stock, as he commented: Finally, Friday, we’re going to hear from Moderna, one of the hottest stocks in the market this year, as people are buzzing about their personal cancer vaccines. All I […]",
      "url": "https://finnhub.io/api/news?id=06a4119caef0e620ec6cd57e6b13408bf20dc49fd85c8a6a1a9c7ac2ddb1cbdc"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Gears Up to Report Q4 Earnings: Is a Beat in the Cards?",
    "summary": "VRTX is set to report Q4 results amid strong Trikafta demand. Alyftrek launches are gaining traction while investors are eyeing Casgevy and Journavx sales.",
    "url": "https://finnhub.io/api/news?id=d4af89dea46cf3b9e8a0210c058140b2b6d334f2e01b36272bf2bd2ee670bcab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770738300,
      "headline": "Vertex Gears Up to Report Q4 Earnings: Is a Beat in the Cards?",
      "id": 139033567,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "VRTX is set to report Q4 results amid strong Trikafta demand. Alyftrek launches are gaining traction while investors are eyeing Casgevy and Journavx sales.",
      "url": "https://finnhub.io/api/news?id=d4af89dea46cf3b9e8a0210c058140b2b6d334f2e01b36272bf2bd2ee670bcab"
    }
  },
  {
    "ts": null,
    "headline": "Earnings live: Spotify stock jumps on subscriber growth, CVS earnings beat, BP halts stock buybacks",
    "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
    "url": "https://finnhub.io/api/news?id=1e88c3324595247983d0b246c28fc5d0ca855087b8dadb9fa4549fa60f373303",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770729358,
      "headline": "Earnings live: Spotify stock jumps on subscriber growth, CVS earnings beat, BP halts stock buybacks",
      "id": 139029597,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
      "url": "https://finnhub.io/api/news?id=1e88c3324595247983d0b246c28fc5d0ca855087b8dadb9fa4549fa60f373303"
    }
  },
  {
    "ts": null,
    "headline": "Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico",
    "summary": "Signed Memorandum of Understanding supports \"Plan Mexico,\" Mexico's strategic initiative to build a local mRNA ecosystem and strengthen health security Strategic agreement will enable access to Moderna's respiratory vaccine portfolio as well as a ...",
    "url": "https://finnhub.io/api/news?id=bb03903802129343f01526e7e334a38b4a6d489b3c00432f77d620ff4c2315ec",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770724800,
      "headline": "Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico",
      "id": 139028545,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Signed Memorandum of Understanding supports \"Plan Mexico,\" Mexico's strategic initiative to build a local mRNA ecosystem and strengthen health security Strategic agreement will enable access to Moderna's respiratory vaccine portfolio as well as a ...",
      "url": "https://finnhub.io/api/news?id=bb03903802129343f01526e7e334a38b4a6d489b3c00432f77d620ff4c2315ec"
    }
  },
  {
    "ts": null,
    "headline": "What Does the Street Think About Moderna, Inc. (MRNA)?",
    "summary": "Moderna, Inc. (NASDAQ:MRNA) is one of the best healthcare stocks under $50 to invest in. Morgan Stanley reiterated a Hold rating on Moderna, Inc. (NASDAQ:MRNA) on February 2, setting a price target of $28.00. In a separate development, Moderna, Inc. (NASDAQ:MRNA) announced on January 29 a strategic collaboration with Recordati for the advancement of the […]",
    "url": "https://finnhub.io/api/news?id=26e4e1b332c7e59c5f623ebf0cbd9d31b311f62e7fcbe3d0b9aeb5297e5be352",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770723705,
      "headline": "What Does the Street Think About Moderna, Inc. (MRNA)?",
      "id": 139028546,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna, Inc. (NASDAQ:MRNA) is one of the best healthcare stocks under $50 to invest in. Morgan Stanley reiterated a Hold rating on Moderna, Inc. (NASDAQ:MRNA) on February 2, setting a price target of $28.00. In a separate development, Moderna, Inc. (NASDAQ:MRNA) announced on January 29 a strategic collaboration with Recordati for the advancement of the […]",
      "url": "https://finnhub.io/api/news?id=26e4e1b332c7e59c5f623ebf0cbd9d31b311f62e7fcbe3d0b9aeb5297e5be352"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Signs Five-Year MoU With Mexico, BIRMEX And Liomont To Supply Respiratory Vaccines And Transfer Technology For In-Country COVID-19 Vaccine Manufacturing",
    "summary": "Moderna Signs Five-Year MoU With Mexico, BIRMEX And Liomont To Supply Respiratory Vaccines And Transfer Technology For In-Country COVID-19 Vaccine Manufacturing",
    "url": "https://finnhub.io/api/news?id=89c3565c9a43712a352c8874a82806fd7439d0f5a3f6aa27b754ee1ca16099e1",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770711245,
      "headline": "Moderna Signs Five-Year MoU With Mexico, BIRMEX And Liomont To Supply Respiratory Vaccines And Transfer Technology For In-Country COVID-19 Vaccine Manufacturing",
      "id": 139030208,
      "image": "",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=89c3565c9a43712a352c8874a82806fd7439d0f5a3f6aa27b754ee1ca16099e1"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Patent Ruling And New Development Chief Reframe mRNA Growth Story",
    "summary": "Moderna (NasdaqGS:MRNA) is involved in an ongoing patent infringement case related to its COVID-19 vaccine, with a recent court ruling addressing claims from Arbutus Biopharma and Genevant. The company has appointed Dr. David Berman, an immunotherapy drug development veteran, as its new Chief Development Officer. Investors are watching how the legal process and the leadership change might influence Moderna's COVID-19 vaccine business and broader research pipeline. Moderna is best known for...",
    "url": "https://finnhub.io/api/news?id=17ab224d272a5d14b7bb9ab052e5b3345c12fbcee55b25b5bdd6e3882937366b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770710847,
      "headline": "Moderna Patent Ruling And New Development Chief Reframe mRNA Growth Story",
      "id": 139027810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (NasdaqGS:MRNA) is involved in an ongoing patent infringement case related to its COVID-19 vaccine, with a recent court ruling addressing claims from Arbutus Biopharma and Genevant. The company has appointed Dr. David Berman, an immunotherapy drug development veteran, as its new Chief Development Officer. Investors are watching how the legal process and the leadership change might influence Moderna's COVID-19 vaccine business and broader research pipeline. Moderna is best known for...",
      "url": "https://finnhub.io/api/news?id=17ab224d272a5d14b7bb9ab052e5b3345c12fbcee55b25b5bdd6e3882937366b"
    }
  },
  {
    "ts": null,
    "headline": "Should You Buy Moderna Before Feb. 13?",
    "summary": "The biotech has momentum as its quarterly report approaches.",
    "url": "https://finnhub.io/api/news?id=bfb9bfcee0a588191954db3fbcc859531706f9f72b3d5de738faf5e557800714",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770698100,
      "headline": "Should You Buy Moderna Before Feb. 13?",
      "id": 139026611,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The biotech has momentum as its quarterly report approaches.",
      "url": "https://finnhub.io/api/news?id=bfb9bfcee0a588191954db3fbcc859531706f9f72b3d5de738faf5e557800714"
    }
  }
]